{
    "doi": "https://doi.org/10.1182/blood.V122.21.531.531",
    "article_title": "Phenotypic Identification Of Subclones In Multiple Myeloma With Different Genomic Profile, Clonogenic Potential and Drug Sensitivity ",
    "article_date": "November 15, 2013",
    "session_type": "651. Myeloma: Biology and Pathophysiology, excluding Therapy",
    "abstract_text": "The identification of subclones in multiple myeloma (MM) could have clinical implications since the complete eradication of all clones is required to prolong patients\u2019 survival. Hence, there is an unmet need to fully characterize such subclones. In the present study, we started by investigating using multidimensional (23-color) flow cytometry (MFC) the presence of \u22652 distinct bone marrow PC subclones in 116 newly-diagnosed (MM) patients included in the Spanish GEM2010 trial: sequential VMP (9 cycles) followed by Rd (9 cycles) vs alternating VMP with Rd (18 cycles). By principal component analysis (PCA) using the Infinicyt software, the immunophenotypic expression profile (based on the simultaneous evaluation of 23 antigens in single-clonal-PCs) showed the presence of two or more subclones in 35/116 (30%) newly-diagnosed MM patients. The most powerful antigens for the identification of subclonal heterogeneity were CD56, CD27, CD81, CD20, CD33, \u03b27, CD138, CD49e, CD54, HLADR, CD19, CD44 and CXCR4. Then, we investigated the genetic profile of distinct phenotypic subclones (sorted by FACS with purity \u226597%) through high-density Cytoscan750K (n=5) arrays and FISH (n=8). In 2/5 (40%) patients, specific copy number abnormalities (CNA; only those with minimum of 25 consecutive imbalanced markers per segment and minimum 100 Kb length were considered) were present in one clone [del(13q), del(14q), del(20p), +(20q), +(21q), or del(22q)] but absent in the other. Similar results were observed by FISH while investigating those probes used as part of the clinical workout. Noteworthy, in three cases del(17p13) was detected in only one subclone, whereas del(13q14) was restricted to one subclone in two patients. To assess the clonogenic potential of distinct phenotypic subclones detected in the whole malignant PC compartment, these were sorted by MFC and seeded in coculture with the human mesenchymal cell line hTERT (with Methocult\u00ae supplemented with lymphocyte conditioned medium (10%) plus 20 ng/ml IL-6 plus 20 ng/ml IGF-1). In 2 out of 7 patients (29%) we observed different clonogenic potential between two patient-specific subclones (patient 1, 208 vs 0 colonies; patient 2, 5 vs 1 colony). Finally, we aimed to investigate if distinct phenotypic subclones display different chemoresistance. To address this question, we compared the immunophenotypic expression profile of paired baseline vs MRD clonal PC in 9 patients enrolled in the Spanish GEM2010 trial in which \u22652 subclones were identified at diagnosis. Our results show a phenomenon of clonal restriction in 7/9 (78%) patients after chemotherapy, indicating that among the initial tumor bulk, only specific subclones are primary chemoresistant (i.e.: MRD) in patients otherwise achieving a serological response. As an example, in one patient showing at diagnosis four clonal PC subsets (CD33-/CD117-, CD33+/CD117-, CD33+/CD117+ and CD33+/CD117+), only one subclone (CD33-/CD117-) persisted after 9 cycles of alterning Rd-VMP. In conclusion, our results show that distinct phenotypic subclones translate into a different cytogenetic profile and clonogenic potential. Since the balance between different subclones may change over the course of treatment, so may change the extent of specific cytogenetic abnormalities and the patient risk. Thus, careful monitoring of specific subclones may have implications towards an adapted therapy to overcome chemoresistant cells. This work was supported by funding from the RTICC-Hematology Group (RD12/0036/0058) , the Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC) (GCB120981SAN) and Multiple Myeloma Research Foundation (MMRF) 2012 Research Fellow Award (B Paiva) Disclosures: No relevant conflicts of interest to declare.",
    "topics": [
        "culture media, conditioned",
        "genetic profile",
        "multiple myeloma",
        "phenotype",
        "cd33 antigen",
        "proto-oncogene protein c-kit",
        "antigens",
        "antigens, cd27",
        "cd19 antigens",
        "cd20 antigens"
    ],
    "author_names": [
        "Teresa Pa\u00edno",
        "Bruno Paiva",
        "Jos\u00e9 M Sayagu\u00e9s",
        "Ines Mota",
        "Tiago Carvalheiro",
        "Luis A Corchete",
        "Norma C Guti\u00e9rrez, MD, PhD",
        "Irene Aires-Mejia",
        "Maria Luz Sanchez",
        "Paloma Barcena",
        "Enrique M. Ocio",
        "Albert Oriol, MD",
        "Miguel T Hernandez",
        "Maria Asunci\u00f3n Echeveste",
        "Artur Paiva, PhD",
        "Joan Blade, MD",
        "Alberto Orfao",
        "Maria Victoria Mateos, MD, PhD",
        "Jesus F San Miguel, MD, PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Teresa Pa\u00edno",
            "author_affiliations": [
                "Centro de Investigaci\u00f3n del C\u00e1ncer, IBMCC/CSIC - Universidad de Salamanca, Salamanca, Spain, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Bruno Paiva",
            "author_affiliations": [
                "Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jos\u00e9 M Sayagu\u00e9s",
            "author_affiliations": [
                "Servicio General de Citometr\u00eda y Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain, "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ines Mota",
            "author_affiliations": [
                "Servicio General de Citometr\u00eda y Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Tiago Carvalheiro",
            "author_affiliations": [
                "Centro do Sangue e da Transplanta\u00e7\u00e3o de Coimbra, Instituto Portugu\u00eas do Sangue e da Transplanta\u00e7\u00e3o, Coimbra, Portugal, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luis A Corchete",
            "author_affiliations": [
                "Centro de Investigaci\u00f3n del C\u00e1ncer, Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer/Consejo Superior de Investigaciones Cient\u00edficas-Universidad de Salamanca, Salamanca, Spain, "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Norma C Guti\u00e9rrez, MD, PhD",
            "author_affiliations": [
                "Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain, "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Irene Aires-Mejia",
            "author_affiliations": [
                "IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain, "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Luz Sanchez",
            "author_affiliations": [
                "Servicio General de Citometr\u00eda y Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain, "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paloma Barcena",
            "author_affiliations": [
                "Servicio General de Citometr\u00eda y Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain, "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Enrique M. Ocio",
            "author_affiliations": [
                "Hospital Universitario de Salamanca - IBSAL, Salamanca, Spain, "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Albert Oriol, MD",
            "author_affiliations": [
                "Hospital Germans Trias i Pujol, Barcelona, Spain, "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Miguel T Hernandez",
            "author_affiliations": [
                "Hospital Universitario de Canarias, La Laguna, Spain, "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Asunci\u00f3n Echeveste",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda, Hospital Universitario Donostia, San Sebastian, Spain, "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Artur Paiva, PhD",
            "author_affiliations": [
                "Centro do Sangue e da Transplanta\u00e7\u00e3o de Coimbra, Instituto Portugu\u00eas do Sangue e da Transplanta\u00e7\u00e3o, Coimbra, Portugal, "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joan Blade, MD",
            "author_affiliations": [
                "Hematology, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain, "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alberto Orfao",
            "author_affiliations": [
                "Servicio General de Citometr\u00eda y Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain, "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Victoria Mateos, MD, PhD",
            "author_affiliations": [
                "Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain, "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jesus F San Miguel, MD, PhD",
            "author_affiliations": [
                "Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-28T09:38:32",
    "is_scraped": "1"
}